Home › Trial NCT07188584
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
- Trial IDNCT07188584
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorMing-Yuan Chen
- Enrollment166
- Start date2025-08-20
- ConditionsNasopharyngeal Carcinoma (NPC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.